Skip to main content
Clinical Trials/NCT02632097
NCT02632097CompletedNot Applicable

Randomized Prospective Double-Blinded Study of Histoacryl™Mesh Fixation Compared to Conventional Non-absorbable Suture Fixation During Lichtenstein Hernioplasty

Hospital Plató1 site in 1 country370 target enrollmentStarted: March 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
370
Locations
1
Primary Endpoint
Acute Postoperative Pain

Study Overview

Brief Summary

This is a prospective, randomized double-blinded study to find out if mesh fixation with n-butyl-2-cyanoacrylate (NBCA) are more painless than conventional mesh fixation with sutures in inguinal hernia operation (Lichtenstein procedure) in day-case surgery. Our hypothesis is that glue fixation is safe, simple and fast method compared to conventional Lichtenstein technique.

Detailed Description

Hypothesis:

  1. To use glue (instead of sutures) for mesh fixation during open hernioplasty causes a lower immediate postoperative pain.
  2. The use of Histoacryl is associated to a lower postoperative complications rate.
  3. The use of Histoacryl is not associated to a higher hernia recurrence rate.

Methods:

350 patients with inguinal hernia undergone Lichtenstein operation in day-case surgery setting. Mesh fixation is performed using 2 methods: cyanoacrylate glue: Histoacryl™ (n=175: Group H), and non-absorbable sutures: polypropylene 2/0 (n=175: Group S). Operative time and pain scores, immediate postoperative outcome are followed 1, 7, 30 days and 1 and 5 years postoperatively.

Surgeon doesn't know previously which fixation method will be used in each patient. This method (glue or sutures) is decided intraoperatively, when mesh is placed, using a blind randomization code (www.randomizer.org) Patients are discharged (day-case surgery) if adequate pain control, oral tolerance and spontaneous diuresis is achieved, and after examination by the surgeon in order to discard immediate complications. Postoperative oral treatment is prescribed to patients of both groups: dexketoprofen 25 mg/8 h + paracetamol 1 gr/8.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •unilateral inguinal hernia
  • •primary hernia

Exclusion Criteria

  • •femoral hernia
  • •recurrent inguinal hernia
  • •immunosuppression (including corticosteroids, radiotherapy, chemotherapy)
  • •chronic renal failure (hemodialysis)
  • •active infection
  • •pregnancy
  • •allergy to polypropylene
  • •patient's refusal

Arms & Interventions

Histoacryl

Experimental

Intervention: Lichtenstein Hernioplasty with Histoacryl™(cyanoacrylate glue 0.5 ml) for mesh fixation (Optilene™ mesh 60 g/m2 (B. Braun))

Intervention: Lichtenstein Hernioplasty with Histoacryl (Procedure)

Suture

Experimental

Intervention: Lichtenstein Hernioplasty with Sutures (polypropylene 2/0) to fix the Optilene™ mesh 60 g/m2 (B. Braun)

Intervention: Lichtenstein Hernioplasty with Sutures (Procedure)

Outcomes

Primary Outcomes

Acute Postoperative Pain

Time Frame: 30 days

pain scores (VAS 0-10) after surgery

Operating Time

Time Frame: 30 days

operating time needed to perform hernioplasty

Secondary Outcomes

  • Postoperative Complications(30 days)
  • Early Recurrence Rate(1 year)
  • Chronic Pain(1 year)
  • Late Recurrence Rate(5 years)

Investigators

Sponsor
Hospital Plató
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials